ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01896102
Brief Title: A Phase 2/3 Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

First Submitted : March 22, 2013
First Submitted that Met QC Criteria : July 8, 2013
First Posted : July 11, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : May 15, 2018
Last Update Posted : May 16, 2018